后COVID综合征和并发症负担之间的关系使用查尔森并发症指数进行评估
Lorenzo Falsetti1, Vincenzo Zaccone2, Luca Santoro3
1Clinica Medica, Department of Clinical and Molecular Sciences, Marche Polytechnic University, 60126 Ancona, Italy.
查尔森并发症指数 (CCI) 与COVID-19后综合征有显著的相关性. 较高的CCI得分表明伴随性疾病的负担更大,以及患上COVID-19后症状的风险增加.
科学领域:
- 医学研究 医学研究
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 后COVID-19综合征表现出持续的症状超过12周后感染.
- 患有慢性疾病的人面临更高的COVID-19后发展的风险.
- 查尔森并发症指数 (CCI) 量化并发症负担并预测结果.
研究的目的:
- 调查CCI测量的并发症负担与COVID-19后综合征发生率之间的相关性.
- 评估CCI在识别长期COVID-19症状风险患者中的预测价值.
主要方法:
- 分析了一组3636名先前接受COVID-19入院的门诊患者.
- 收集的数据包括人口统计,COVID-19严重程度和COVID-19后症状.
- 查尔森并发症指数 (CCI) 被计算;其与后COVID-19综合征的关联被使用后勤回归来评估.
主要成果:
- 在COVID-19后症状数量和CCI之间发现了显著的关联.
- 患有后COVID-19综合征的患者表现出更高的并发症负担 (更高的CCI).
- 在CCI≥1 (OR:2.961) 和CCI≥4 (OR:6.062) 的患者中观察到COVID-19后综合征的风险增加.
结论:
- 后COVID-19患者表现出更大的临床复杂性和更高的并发症负担,这体现在CCI得分的升高.
- 较高的CCI与患COVID-19后综合征的风险增加有关.
- 一个或多个CCI点的存在使风险增加了三倍,而四个或多个点使风险增加了六倍.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
08:25Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
Published on: December 6, 2024
相关概念视频
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Factors Affecting Illness
For instance, risk factors are connected to illness,...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
